Vertex Pharmaceuticals Inc VRTX:NASDAQ

Last Price$287.96NASDAQ Previous Close - Last Trade as of 3:59PM ET 5/29/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$287.96 (1)
Ask (Size)$288.50 (1)
Day Low / HighN/A - N/A
Volume5.4 M
  • Latest Stories
  • Commentary and Analysis
CRISPR Therapeutics, Vertex Pharma Add Another FDA Designation for CTX001 Stem Cell Therapy; Stock Jumps 12%
11:06AM ET 5/11/2020 MT Newswires

CRISPR Therapeutics (CRSP) and Vertex Pharmaceuticals (VRTX) said on Monday the US Food and Drug Administration (FDA) has granted Regenerative Medicine...

Standard & Poor's 500 Slips Lower For the Week as Wall Street Cools on Economic Re-Opening
4:32PM ET 5/01/2020 MT Newswires

The Standard & Poor's 500 closed lower for a second straight week as Wall Street took a more sobering view of the re-opening of the economy and as...

Insider Trends: Vertex Pharmaceuticals Insider Sale for Taxes Adds to 90-Day Selling Trend
4:29PM ET 5/01/2020 MT Newswires

On Apr 30, 2020, Charles F Wagner, EVP & CFO, completed a sale of 547 Vertex Pharmaceuticals (VRTX) shares for approximately $137,406 to meet tax...

Consensus Estimates for Vertex Pharmaceuticals' Q2, 2020, 2021 Years Raised
1:50PM ET 5/01/2020 MT Newswires

Consensus estimates for Q2 ending June 30, 2020, and the full year forecasts for 2020 and 2021 for the years ending on December 31 for Vertex...

Vertex Pharmaceuticals Gets Positive Opinion for Label Expansion of Cystic Fibrosis Drug
7:19AM ET 5/01/2020 MT Newswires

Vertex Pharmaceuticals (VRTX) said Friday the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion for the...

--Analyst Actions: JP Morgan Raises Vertex Pharmaceuticals' Price Target to $281 From $260, Maintains Overweight Rating
3:33PM ET 4/30/2020 MT Newswires

Price: 248.99, Change: -2.06, Percent Change: -0.82 ...

--Analyst Actions: Goldman Sachs Raises Price Target for Vertex Pharmaceuticals to $290 From $287, Maintains Buy Rating
3:32PM ET 4/30/2020 MT Newswires

Price: 248.68, Change: -2.38, Percent Change: -0.95 ...

--Analyst Actions: Morgan Stanley Raises Price Target for Vertex Pharmaceuticals to $277 From $258, Maintains Overweight Rating
3:31PM ET 4/30/2020 MT Newswires

Price: 248.64, Change: -2.41, Percent Change: -0.96 ...

--Analyst Actions: HC Wainwright Lifts Vertex Pharmaceuticals Price Target to $295 From $270, Maintains Buy Rating
12:27PM ET 4/30/2020 MT Newswires

Price: 249.48, Change: -1.57, Percent Change: -0.63 ...

--Analyst Actions: Oppenheimer Lifts Vertex Pharmaceuticals' Price Target to $305 From $265, Keeps Outperform Rating
12:09PM ET 4/30/2020 MT Newswires

Price: 249.49, Change: -1.56, Percent Change: -0.62 ...